HydralAzine HCl Injection Recall

Novaplus label HydralAzine HCl Injection Removed from the Market
October 4, 2006 - The Food and Drug Administration (FDA) has recalled Novaplus label HydralAzine HCl Injection (USP, 20 mg/mL, 25 x 1 mL single dose vials, for intramuscular or intravenous use) from the market due to a presence of particulate matter.

Additional information can be found at: www.fda.gov/bbs/topics/enforce/2006/ENF00972.html#DRUGS.